Patent Application
20210186754
The subject matter described herein relates generally to systems, methods, and devices for maintaining a gonioprism in a fixed position with respect to an eye during a surgical or other procedure.
Currently, there is a great deal of clinical interest, including research and development, in the use of very small, intraocularly implantable devices for the treatment of glaucoma. These devices generally fall into a particular category of devices and are collectively referred to as Minimally Invasive Glaucoma Surgery (MIGS) devices. Presently, at least four devices have been approved for use by the United States Food and Drug Administration. The first is the iStent, which is manufacturer by Glaukos and is placed in the ocular trabecular meshwork. The second is the Cy-pass, which is manufactured by Alcon and is placed in the ocular supra-choroidal space. The third is the iTrack, manufactured by Ellex, which is a micro-catheter used to dilate Schlemm's canal. The fourth is the Xen Gel Stent, manufactured by Allergan, that helps to create a filtration pathway from the anterior chamber, through the sclera, and into the subconjunctival space. Each of these devices is designed to improve aqueous fluid out-flow and to reduce intraocular pressure. These devices are surgically placed in an area within the eye called “the angle.”
The angle is an area located within the anterior chamber of the eye where the cornea and the iris join 360 degrees around the periphery of the iris and cornea. This area of the anterior chamber is located under the peripheral corneal area and cannot be seen or otherwise visualized by looking directly at the eye. Therefore, in order to visualize the angle, a physician must be able to look around this peripheral corneal area, similar to looking around a corner. Devices that have been employed to perform this action include small hand held optical prisms, referred to as gonioprisms.
Gonioprisms are devices that are used during medical procedures, especially on the eye, to view obscured or hidden structures by providing angular views around intermediate anatomical structures. They generally provide a field of view of anterior ocular chamber structures and anterior chamber angles during procedures that provide for implantation of devices, application of lasers, and other surgical manipulation of structures in the eye, including goniotomy. Gonioprisms must be correctly positioned for effective use. Various examples of prior art gonioprism positioning tools have been developed and most of these require that they be held by hand during a surgical procedure, usually by the surgeon. These tools are usually held in the surgeon's hand and must be maintained in a particular position to correctly view the desired structures.
While some gonioprism positioning tools include extensions, flanges, handles, or other structures designed to help maintain position with the ocular globe during surgical procedures, they can be unwieldy and may introduce an increased surgeon manipulation of the device to achieve the desired visualization effects. Additionally, most of these tools require the surgeon to maintain a particular amount of contact pressure with the patient's cornea or other ocular structures, which can be challenging. Where contact pressure by the surgeon is too light, the interface between the gonioprism lens and the surface of the cornea may be lost, and the surgeon will no longer be able to see the desired location or structures. Where contact pressure by the surgeon is too great, the cornea may crinkle or fold into Descemet's membrane in the cornea, resulting in the surgeon no longer being able to see the desired location or structures. Even experts in the field that specialize in these types of ocular surgery procedures may struggle with positioning related challenges. Poor visualization as a result of positioning problems is known to be one of the primary impediments to successful ocular surgery procedures.
A number of examples of pertinent prior art gonioprisms and positioning tools exist. One example is U.S. Pat. No. 7,125,119, which describes a standard gonioprism with a contact lens to fit on a cornea specifically for laser procedures like SLT. Another example is WIPO Publication No. 99/20171, which describes a contact lens with a vacuum to maintain contact with an eye surface for vitreoretinal surgery. This lens has an access port to allow the introduction of instruments into the posterior portion of the eye behind the lens, but the access port does not pass through a vacuum element area. WIPO Publication No. 92/07501 describes a contact lens that provides a wide field of vision for retinal ophthalmoscopy. U.S. Pat. No. 5,046,836 describes a contact lens for retinal indirect ophthalmoscopy. U.S. Pat. No. 5,200,773 describes a contact lens for retinal indirect ophthalmoscopy. U.S. Pat. No. 5,886,812 describes a contact lens connected to a microscope for retinal indirect ophthalmoscopy. U.S. Patent Pub. No. 2012/0257167A1 describes a hand-held gonioscope, including a prism with a handle. U.S. Pat. No. 8,070,290 describes another hand held gonioscope, including a prism with a handle. U.S. Pat. No. 7,419,262 describes yet another hand held gonioscope including a prism with a handle. Each of these prior art disclosures is incorporated herein by reference. However, each these devices lack the specific features and do not provide the benefits of the embodiments described herein.
It is therefore desirable to provide improved systems, devices, and methods that allow a gonioprism to maintain optimal positioning with respect to a corneal location by selectively applying a safe and effective amount of vacuum pressure to an external eye surface which can improve hands-free visualization of ocular structures through the gonioprism and allow access to structures within the anterior chamber.
Disclosed are systems, devices, and methods that maintain optimal positioning of a gonioprism with respect to a corneal location. In various embodiments, this is achieved by selectively applying a safe and effective amount of vacuum pressure to an external eye surface and results in improved, hands-free visualization of ocular structures through the gonioprism.
These systems, devices, and methods include the use of vacuum docking of a gonioprism to an external eye surface that provides a removable fixation to the eye and allows a physician to accurately and effectively treat parts of the eye, including the cornea. In some embodiments, gonioprisms can be removably or detachably coupled with a vacuum dock, while in others, they may be fixedly coupled. Vacuum mechanisms can include active or passive pumping mechanisms, vacuum syringes including one or more valves, and others in various embodiments.
Illustrated in the accompanying drawing(s) is at least one of the best mode embodiments of the present invention.
Before the present subject matter is described in detail, it is to be understood that this disclosure is not limited to the particular embodiments described, as such may vary. It should also be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.
Disclosed herein are systems, devices and methods for improved, hands-free visualization of intra-ocular structures through a gonioprism during medical procedures. In various embodiments, these can include standard, modified, or customized vacuum docks that, when coupled with gonioprisms and engaged, maintain a fixed position with respect to a coupled eye surface location. As such, they can remain fixed to the eye for delicate procedures in which physicians or surgeons would benefit from having full use of both hands without having to constantly maintain a gonioprism in position using one hand.
Example embodiments disclosed herein included gonioprisms that are removable or detachable using screwing, clamping, latching, or other mechanisms with a vacuum docking station. In various embodiments, gonioprism docking devices can include one or more disposable components. In some embodiments, these components can be reusable if properly sterilized.
In some embodiments, other docking functionality can also be included. This can be done in combination with or as substitution for vacuum docking functionality in various embodiments. To elaborate, mechanical docking with one or more mechanical structures can be provided for in some embodiments. This can include docking with a speculum, with sutures, with lighting components, with sensors, with measurement components, and with others, as appropriate. In some embodiments, this can be performed during a pre-procedure process, while in other embodiments, it can be performed during a procedure.
In some embodiments, systems, devices, and methods can include an apparatus that makes and maintains contact a portion of a patient's cornea and not another portion of the eye, and which provide access to the anterior chamber.
To elaborate, these mechanisms can generally be considered docking mechanisms, whereby a gonioprism is adapted for coupling with a docking device using the docking mechanism. These docking mechanisms can allow for docking before or during a procedure. Additionally, in some embodiments these docking mechanisms can allow for orientation and manipulation of docked gonioprisms to desired orientations after docking.
As shown, one or more vents or channels 430 in a portion of the gonioprism can allow ingress, egress, or both from ocular surfaces. For example, balanced salt solutions (“BSS”) that are used to help irritate the eye, saline solution, and other fluids can be moved through the vent 430 to assist in the procedure or allow natural fluid flow with respect to normal eye functioning. Thus, vents 430 can provide an interface with the vacuum docking device as a gonioprism is rotated or otherwise coupled into an operable position with respect to the vacuum docking device 420.
Also shown in the example embodiment is a vacuum hose 440. This hose 440 can be removable or permanently fixed to the vacuum docking device 410 at a vacuum hose interface 450 and, when a vacuum is coupled at a distal hose end, the proximal hose end will draw fluid, such as air, through the hose. This can operate to seal the gonioprism 420 to the docking device 410 in some embodiments. In some embodiments, it can operate to seal the docking device 420 and gonioprism 410 to an ocular surface.
Additionally, it should be understood that in various embodiments, seals can prevent fluid movement between one or more components, and may be slidably or otherwise engaged between components. For example, one or more rubber rings can be provided at the interface between the gonioprism and the vacuum docking device.
Skirt 530 can be an elastomeric material in various embodiments. As such it can be soft, pliable plastic, moderate plastic, or slightly harder plastic as appropriate. Gonioprisms 520 can include a lens 540 made of polished glass or molded and polished plastic material that is about 11 mm to about 12.5 mm or 13 mm. Vacuum docking device base can generally be a hard material shell that is operable to create and sustain a vacuum when engaged.
Vacuum docking device skirt 530 and base can be opaque in some embodiments, such that they do not allow light to penetrate through their surfaces. Gonioprism lens 540 is generally transparent and allows light to pass through a distal and proximal end in one or both direction in order to view the subject material below. Lighting in many embodiments is provided by a microscope, while in some embodiments, ambient lighting in the operation room can be sufficient. Also, in some embodiments, lighting mechanisms that are coupled with the docking device 510 or gonioprism 530 can be provided. These may include one or more lighting elements, such as LED's, that are powered using one or more power sources, such as removable or permanently attached batteries or power cables. It should be understood that on and off switches or buttons can allow for their associated effects.
In some embodiments, docking device skirt 530 can include a pre-operative treatment that aids in creating an effective vacuum seal, protects the ocular surface from damage, or performs some other functionality.
As shown in the example embodiment, the gonioprism 520 can detachably or removably couple with the vacuum docking device 510. The vacuum docking device 510 can include a vacuum skirt 530 that removably couples with at least a portion of a sclera of an eye for stability. Vacuums contemplated herein are generally operable to perform the functions described herein without requiring an excessive amount of vacuum pressure that may cause injury to the patient. Vacuum devices providing suction can be integrated with vacuum docking devices in some embodiments. Once a vacuum has been engaged, the vacuum docking device generally remains fixed with respect to its position with respect to its engaged eye surface. In some embodiments, the skirt and device can be slightly moved or repositioned, even after the vacuum has been engaged.
Although generally described herein are various vacuum docking mechanisms, other docking mechanisms can be provided in various embodiments. For example, additional mechanical docking with one or more mechanical structures can be provided for in some embodiments, including: docking with tools such as a speculum, with sutures, with lighting components, with sensors, with measurement components, and with others, as appropriate. In some embodiments, this can be performed during a pre-procedure process, while in other embodiments, it can be performed during a procedure.
While the embodiments herein describe a gonioprism, the gonioprism may be replaced or supplemented by any other optical device, including but not limited to surgical contact lenses, Retinal Vitrectomy Lenses, Indirect Contact Surgical Lenses, Aspheric Macular Lenses. Additionally, the vacuum pressure (or other sealing pressures) being applied/exerted on both the skirt and the cornea, in some embodiments, the vacuum pressure (or other sealing pressures) may be applied/exerted to the skirt only and not the cornea to reduce pressure induced folds in the cornea which may tend to reduce visualization. Although shown as an port/opening in one or more components in the device, in some embodiments the port/opening may not be configured as shown in the figures. For example, in some embodiments the skirt may not be completely circumferential and instead may include one or more walls defining a triangular portion or slice where procedures can be executed. As such, a port can be defined by part of a discontinuation of a circumferential surface or wall. Thus, in some embodiments, ports do not involve nearby engagement of the vacuum docking system.
Additionally, in some embodiments a vacuum dock does not engage an entire area below a docking device or an entire area below a particular component of a docking device. For example, where a skirt is circumferential in nature, a vacuum pump and docking device configuration may not create a vacuum seal within the entire circumference of the skirt. Instead, it may engage an ocular surface at one or more specific points to create the vacuum seal and maintain device positioning using suction.
Although not shown in the example embodiment, in some embodiments automatic digital or analog vacuum gauges can be included that display vacuum pressure present within the interior of the docking device when in use. As such, these gauges can be coupled with and influenced by sensors, which are not shown.
As shown in the example embodiment, the gonioprism can be rotated with respect to the vacuum docking device, which, in some embodiments, can occur during a procedure. Although not shown, upward and downward or proximal and distal movement of the gonioprism can be actuated using a screw, lever, or other appropriate mechanism.
As used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.
The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
It should be noted that all features, elements, components, functions, and steps described with respect to any embodiment provided herein are intended to be freely combinable and substitutable with those from any other embodiment. If a certain feature, element, component, function, or step is described with respect to only one embodiment, then it should be understood that that feature, element, component, function, or step can be used with every other embodiment described herein unless explicitly stated otherwise. This paragraph therefore serves as antecedent basis and written support for the introduction of claims, at any time, that combine features, elements, components, functions, and steps from different embodiments, or that substitute features, elements, components, functions, and steps from one embodiment with those of another, even if the following description does not explicitly state, in a particular instance, that such combinations or substitutions are possible. It is explicitly acknowledged that express recitation of every possible combination and substitution is overly burdensome, especially given that the permissibility of each and every such combination and substitution will be readily recognized by those of ordinary skill in the art.
In many instances entities are described herein as being coupled to other entities. It should be understood that the terms “coupled” and “connected” (or any of their forms) are used interchangeably herein and, in both cases, are generic to the direct coupling of two entities (without any non-negligible (e.g., parasitic) intervening entities) and the indirect coupling of two entities (with one or more non-negligible intervening entities). Where entities are shown as being directly coupled together or described as coupled together without description of any intervening entity, it should be understood that those entities can be indirectly coupled together as well unless the context clearly dictates otherwise.
While the embodiments are susceptible to various modifications and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that these embodiments are not to be limited to the particular form disclosed, but to the contrary, these embodiments are to cover all modifications, equivalents, and alternatives falling within the spirit of the disclosure. Furthermore, any features, functions, steps, or elements of the embodiments may be recited in or added to the claims, as well as negative limitations that define the inventive scope of the claims by features, functions, steps, or elements that are not within that scope.
This application is a U.S. National Stage under 35 USC 371 of International Patent Application No. PCT/US2018/034783, filed May 25, 2018, which claims priority to U.S. Provisional Patent Application No. 62/511,887, filed May 26, 2017, the disclosures of both which are hereby incorporated in their entireties by reference.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US18/34783 | 5/25/2018 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 62511887 | May 2017 | US |
